According to news reports, Glaxo (GlaxoSmithKline) has agreed to pay a $75 million settlement in the Relafen Antitrust Lawsuit. The settlement has apparently been approved by a the District Court Judge.
Read my prior post discussing the holding that may have prompted the settlement.